表紙
市場調查報告書

末梢血管支架:醫療設備的開發平台評估

Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 223329
出版日期 內容資訊 英文 286 Pages
訂單完成後即時交付
價格
Back to Top
末梢血管支架:醫療設備的開發平台評估 Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月20日內容資訊: 英文 286 Pages
簡介

本報告提供全球末梢血管支架市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 末梢血管支架概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 末梢血管支架心臟:各企業現在臨床實驗中的開發中產品

  • 末梢血管支架的企業:各臨床實驗階段的開發中產品
  • 末梢血管支架:各臨床實驗階段的開發中產品

第5章 末梢血管支架的企業·產品概要

  • 3D Biotek LLC
  • 480 Biomedical In
  • Abbott Vascular Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • C. R. Bard Inc
  • Cardiatis SA
  • Cook Medical Inc
  • Cordis Corp
  • Corinnova Inc
  • Cytograft Tissue Engineering Inc
  • Efferent Labs Inc
  • Electroformed Stents Inc
  • Elixir Medical Corp
  • Hexacath
  • InspireMD Inc
  • Intact Vascular, LLC
  • Lifetech Scientific (Shenzhen) Co., Ltd
  • LimFlow GmbH
  • Medinol Ltd
  • Medtronic plc
  • MicroVention, Inc.
  • Natec Medical Ltd
  • Nexeon MedSystems Inc
  • Nipro
  • Northwestern University
  • NSVascular, Inc.
  • PeriTec Biosciences Ltd
  • Stron Medical
  • Synergy Flow Ltd
  • Taewoong Medical Co.,Ltd.
  • Tepha Inc
  • TissueGen Inc
  • University of Michigan
  • University of Texas Medical Branch at Galveston
  • Vascular Bioresorbable Technologies
  • Vascular Concepts Ltd
  • Veniti Inc
  • Veryan Medical Limited
  • VueKlar Cardiovascular Ltd
  • Xenogenics Corporation

第6章 末梢血管支架市場:目前的趨勢 (全77件)

第7章 建議

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0891EPD

GlobalData's Medical Devices sector report, "Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2019" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 8
  • 1.2 List of Figures 13

2 Introduction 14

  • 2.1 Peripheral Vascular Stents Overview 14

3 Products under Development 15

  • 3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development 15
  • 3.2 Peripheral Vascular Stents - Pipeline Products by Segment 16
  • 3.3 Peripheral Vascular Stents - Pipeline Products by Territory 17
  • 3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path 18
  • 3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date 19
  • 3.6 Peripheral Vascular Stents - Ongoing Clinical Trials 20

4 Peripheral Vascular Stents - Pipeline Products under Development by Companies 21

  • 4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development 21
  • 4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development 23

5 Peripheral Vascular Stents Companies and Product Overview 26

  • 5.1 3D Biotek LLC Company Overview 26
    • 5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.2 Abbott Vascular Inc Company Overview 27
    • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.3 AlviMedica Medical Technologies Inc Company Overview 31
    • 5.3.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.4 AndraTec GmbH Company Overview 38
    • 5.4.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.5 Arterius Ltd Company Overview 39
    • 5.5.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.6 Boston Scientific Corp Company Overview 40
    • 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.7 Cardiatis SA Company Overview 49
    • 5.7.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.8 Cook Medical Inc Company Overview 50
    • 5.8.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.9 Cordis Corp Company Overview 54
    • 5.9.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.10 Corinnova Inc Company Overview 56
    • 5.10.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview 57
    • 5.11.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.12 Efemoral Medical LLC Company Overview 58
    • 5.12.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.13 Efferent Labs Inc Company Overview 59
    • 5.13.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.14 Electroformed Stents Inc Company Overview 60
    • 5.14.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.15 Elixir Medical Corp Company Overview 63
    • 5.15.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.16 FIT Biotech Oy Company Overview 66
    • 5.16.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.17 ID Nest Medical SAS Company Overview 68
    • 5.17.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.18 InspireMD Inc Company Overview 69
    • 5.18.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.19 Intact Vascular LLC Company Overview 70
    • 5.19.1 Intact Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.20 Kyoto Medical Planning Co Ltd Company Overview 73
    • 5.20.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

6 Peripheral Vascular Stents- Recent Developments 131

  • 6.1 Nov 19, 2019: Data show Zilver PTX leads to fewer complications and shorter hospital stays than traditional bypass surgery 131
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 131
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 133
  • 6.4 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 135
  • 6.5 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 136
  • 6.6 Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer 136
  • 6.7 Nov 07, 2019: Neovasc announces third quarter 2019 financial results 137

7 Appendix 283

  • 7.1 Methodology 283
  • 7.2 About GlobalData 286
  • 7.3 Contact Us 286
  • 7.4 Disclaimer 286

List of Tables

  • Table 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Table 2: Peripheral Vascular Stents - Pipeline Products by Segment
  • Table 3: Peripheral Vascular Stents - Pipeline Products by Territory
  • Table 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Table 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Table 6: Peripheral Vascular Stents - Ongoing Clinical Trials
  • Table 7: Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
  • Table 8: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status
  • Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description
  • Table 12: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: ESPRIT Bioresorbable Vascular Scaffold - Product Status
  • Table 14: ESPRIT Bioresorbable Vascular Scaffold - Product Description
  • Table 15: ESPRIT BTK Bioresorbable Vascular Scaffold - Product Status
  • Table 16: ESPRIT BTK Bioresorbable Vascular Scaffold - Product Description
  • Table 17: Abbott Vascular Inc - Ongoing Clinical Trials Overview
  • Table 18: ESPRIT BTK Bioresorbable Vascular Scaffold - Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)
  • Table 19: ESPRIT BTK Bioresorbable Vascular Scaffold - Pivotal Investigation of Safety and Efficacy for Bioresorbable Scaffold (BRS) Treatment Below The Knee: LIFE-BTK
  • Table 20: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Cre8 BTK - Product Status
  • Table 22: Cre8 BTK - Product Description
  • Table 23: Easy Flype - Product Status
  • Table 24: Easy Flype - Product Description
  • Table 25: Easy HiFlype - Product Status
  • Table 26: Easy HiFlype - Product Description
  • Table 27: Isthmus Logic - Product Status
  • Table 28: Isthmus Logic - Product Description
  • Table 29: NiTiDES - Product Status
  • Table 30: NiTiDES - Product Description
  • Table 31: AlviMedica Medical Technologies Inc - Ongoing Clinical Trials Overview
  • Table 32: NiTiDES - Innovative Sirolimus Self Expanding Drug-eluting Stent for the Treatment of Peripheral Disease: Evaluation of Safety and Efficacy. The Illumina Study (Illumina)
  • Table 33: AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Pillar Bifurcation Reconstruction Device - Product Status
  • Table 35: Pillar Bifurcation Reconstruction Device - Product Description
  • Table 36: Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Bioresorbable Stent - Peripheral Vascular Disease - Product Status
  • Table 38: Bioresorbable Stent - Peripheral Vascular Disease - Product Description
  • Table 39: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Eluvia Drug-Eluting Vascular Stent System - Product Status
  • Table 41: Eluvia Drug-Eluting Vascular Stent System - Product Description
  • Table 42: Gallbladder Drainage System - Product Status
  • Table 43: Gallbladder Drainage System - Product Description
  • Table 44: SAVAL Drug Eluting Stent BTK - Product Status
  • Table 45: SAVAL Drug Eluting Stent BTK - Product Description
  • Table 46: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Status
  • Table 47: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Description
  • Table 48: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 49: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
  • Table 50: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
  • Table 51: Eluvia Drug-Eluting Vascular Stent System - A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-comers with Superficial Femoral Artery and Proximal Popliteal Artery Disease
  • Table 52: Eluvia Drug-Eluting Vascular Stent System - Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
  • Table 53: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Sinai Vein Stent Registry
  • Table 54: SAVAL Drug Eluting Stent BTK - A Randomized Trial Comparing the Drug-eluting Stent (DES) Below-the-knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) Versus Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia
  • Table 55: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Cardiatis FluidSmart 3D Stent - Product Status
  • Table 57: Cardiatis FluidSmart 3D Stent - Product Description
  • Table 58: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Zenith Connection Endovascular Covered Stent - Product Status
  • Table 60: Zenith Connection Endovascular Covered Stent - Product Description
  • Table 61: Zilver Vena Venous Self-Expanding Stent - Product Status
  • Table 62: Zilver Vena Venous Self-Expanding Stent - Product Description
  • Table 63: Cook Medical Inc - Ongoing Clinical Trials Overview
  • Table 64: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
  • Table 65: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Figure 2: Peripheral Vascular Stents - Pipeline Products by Segment
  • Figure 3: Peripheral Vascular Stents - Pipeline Products by Territory
  • Figure 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Figure 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Figure 6: Peripheral Vascular Stents - Ongoing Clinical Trials
Back to Top